Metabolic evaluation of children with global developmental delay

Area of Science:

• Neuroscience
• Genetics
• Pediatrics

Background:

• Global developmental delay (GDD) is a common early-onset neurological condition with diverse causes.
• Diagnosis often requires extensive laboratory tests and brain imaging, which can be costly and may not yield therapeutic benefits.
• Genetic advancements have improved GDD diagnosis, but challenges remain due to overlapping phenotypes and broad clinical spectra of underlying diseases.

Purpose of the Study:

• To highlight the diagnostic challenges in identifying the causes of GDD.
• To emphasize the need for cost-effective strategies for early identification of treatable GDD causes.
• To underscore the importance of timely therapeutic interventions for improved neurodevelopmental outcomes.

Main Methods:

• Review of current diagnostic approaches for GDD.
• Analysis of the role of genetic technology in GDD diagnosis.
• Discussion of the challenges posed by overlapping phenotypes and broad clinical spectra.
• Exploration of strategies for identifying treatable causes of GDD.

Main Results:

• GDD diagnosis is complex, often requiring a multi-faceted approach.
• While genetic testing has advanced GDD diagnosis, it is not always cost-effective or leads to treatment.
• Inborn metabolic errors are a key target for GDD treatment, but represent a small fraction of cases.
• Phenotypic overlap and broad clinical spectra complicate the identification of specific GDD causes.

Conclusions:

• Effective and economical strategies are needed for early GDD diagnosis, particularly for treatable conditions.
• Timely therapeutic interventions based on accurate diagnosis are essential for optimizing neurodevelopmental outcomes in GDD patients.
• Further research into cost-effective diagnostic pathways and understanding of disease spectra is warranted.